
📈 Finance & Markets Daily Briefing
Published: Wednesday, November 4, 2026
Here are the most important Finance & Markets stories from the last 24 hours, hand-picked and rated for relevance and impact.

Top Stories
1. Novo CEO Doustdar ‘Very Optimistic’ About CagriSema
Source: bloomberg | Rating: 8.7/10
Novo Nordisk A/S Chief Executive Officer Mike Doustdar discusses the possible launch of a new obesity drug called CagriSema. "We are hopeful that we will be able to get the timely approval from the FDA at the end of this year and launch it at the beginning of next year," Doustdar says. He speaks on Bloomberg Television after the company boosted its forecast for the year once again, sparking optimism after the new Wegovy pill and the older shot Ozempic helped buoy earnings.
💡 Why it matters: Market participants are watching closely
2. BTIG raises ONE Gas stock price target to $95 on growth outlook
Source: investing | Rating: 7.5/10
💡 Why it matters: AI infrastructure demand is accelerating faster than expected
3. McDonald’s is about to report earnings. Here’s what to expect
Source: cnbc | Rating: 7.4/10

McDonald’s stock has fallen about 11% over the last year.
💡 Why it matters: Major financial institutions adjusting expectations
4. Earnings call transcript: Adtraction tops growth target in Q3 2026 as stock jumps
Source: investing | Rating: 7.2/10
💡 Why it matters: Commercial real estate weakness signals broader economic stress
5. BTIG raises Flywire stock price target to $22 on strong results
Source: investing | Rating: 7.2/10
💡 Why it matters: AI infrastructure demand is accelerating faster than expected
Honorable Mentions
These stories scored between 5.0 and 6.9 — notable, but didn’t crack the top tier.
1. AMD stock jumps 8% on earnings as data center revenue nearly doubles — cnbc (6.9/10) — Read more
2. CVS Health stock holds buy rating at TD Cowen on retail spin report — investing (6.8/10) — Read more
3. Mizuho reiterates CVS Health stock rating amid spinoff reports — investing (6.8/10) — Read more
Delivered by ReDNeK Daily Briefing.
📬 Get tomorrow’s briefing in your inbox
Daily Finance & Markets top stories, hand-picked and ranked. One email, every morning, free.
No spam. Unsubscribe anytime. We never share your email.
